Taiko Pharmaceutical Co Ltd (4574)

Currency in JPY
298.0
+8.0(+2.76%)
Closed·
Earnings results expected in 3 days
4574 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
292.0299.0
52 wk Range
228.0444.0
Key Statistics
Bid/Ask
297.00 / 299.00
Prev. Close
290
Open
293
Day's Range
292-299
52 wk Range
228-444
Volume
195.3K
Average Volume (3m)
120.43K
1-Year Change
-10.241%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4574 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Taiko Pharmaceutical Co Ltd Company Profile

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It also offers sanitation control products under the Cleverin and Cleverin Generator LISPASS name. In addition, the company manufactures and sells wood vinegar-based products. The company exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.

Employees
214
Market
Japan

Compare 4574 to Peers and Sector

Metrics to compare
4574
Peers
Sector
Relationship
P/E Ratio
17.1x21.6x−0.5x
PEG Ratio
0.13−0.190.00
Price/Book
1.8x1.7x2.6x
Price / LTM Sales
2.5x1.7x3.3x
Upside (Analyst Target)
-4.6%45.0%
Fair Value Upside
Unlock20.8%5.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 11, 2025
EPS / Forecast
7.76 / --
Revenue / Forecast
1.82B / 1.64B
EPS Revisions
Last 90 days

4574 Income Statement

FAQ

What Stock Exchange Does Taiko Pharmaceutical Trade On?

Taiko Pharmaceutical is listed and trades on the Tokyo Stock Exchange. TEST JPY

What Is the Stock Symbol for Taiko Pharmaceutical?

The stock symbol for Taiko Pharmaceutical is "4574."

What Is the Taiko Pharmaceutical Market Cap?

As of today, Taiko Pharmaceutical market cap is 14.92B.

What Is Taiko Pharmaceutical's Earnings Per Share (TTM)?

The Taiko Pharmaceutical EPS (TTM) is 16.98.

When Is the Next Taiko Pharmaceutical Earnings Date?

Taiko Pharmaceutical will release its next earnings report on 12 Feb 2026.

From a Technical Analysis Perspective, Is 4574 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Taiko Pharmaceutical Stock Split?

Taiko Pharmaceutical has split 2 times.

How Many Employees Does Taiko Pharmaceutical Have?

Taiko Pharmaceutical has 214 employees.

What is the current trading status of Taiko Pharmaceutical (4574)?

As of 10 Feb 2026, Taiko Pharmaceutical (4574) is trading at a price of 298.0, with a previous close of 290.0. The stock has fluctuated within a day range of 292.0 to 299.0, while its 52-week range spans from 228.0 to 444.0.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.